WO2023214552A1 - トリフルオロメタンスルホニル化剤組成物、及び、トリフルオロメタンスルホニルオキシ化合物またはトリフルオロメタンスルホニル化合物の製造方法 - Google Patents

トリフルオロメタンスルホニル化剤組成物、及び、トリフルオロメタンスルホニルオキシ化合物またはトリフルオロメタンスルホニル化合物の製造方法 Download PDF

Info

Publication number
WO2023214552A1
WO2023214552A1 PCT/JP2023/016923 JP2023016923W WO2023214552A1 WO 2023214552 A1 WO2023214552 A1 WO 2023214552A1 JP 2023016923 W JP2023016923 W JP 2023016923W WO 2023214552 A1 WO2023214552 A1 WO 2023214552A1
Authority
WO
WIPO (PCT)
Prior art keywords
group
carbon atoms
reaction
general formula
mmol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2023/016923
Other languages
English (en)
French (fr)
Japanese (ja)
Inventor
廉 富田
純基 新田
たか子 山崎
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Central Glass Co Ltd
Original Assignee
Central Glass Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Central Glass Co Ltd filed Critical Central Glass Co Ltd
Priority to EP23799482.7A priority Critical patent/EP4506334A4/en
Priority to US18/862,440 priority patent/US20250289781A1/en
Priority to JP2024519216A priority patent/JPWO2023214552A1/ja
Priority to CN202380037379.0A priority patent/CN119137096A/zh
Publication of WO2023214552A1 publication Critical patent/WO2023214552A1/ja
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/26—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids
    • C07C303/28—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids by reaction of hydroxy compounds with sulfonic acids or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/68—One oxygen atom attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/02—Monosaccharides

Definitions

  • the present disclosure relates to a trifluoromethanesulfonylating agent composition capable of trifluoromethanesulfonylating a substrate containing a functional group such as a phenolic hydroxyl group, and a method for producing a trifluoromethanesulfonyloxy compound or a trifluoromethanesulfonyl compound using the composition.
  • Trifluoromethanesulfonylation of substrates having various functional groups is performed. Trifluoromethanesulfonylation of phenolic hydroxyl groups is an important reaction in the synthesis of drug substances or intermediates for pharmaceuticals.
  • Patent Document 1 a method in which a substrate having a phenolic hydroxyl group is reacted with trifluoromethanesulfonic anhydride
  • Patent Document 2 a method in which a substrate having a phenolic hydroxyl group is reacted with trifluoromethanesulfonyl fluoride method
  • Patent Document 3 method of reacting a substrate having a phenolic hydroxyl group with trifluoromethanesulfonyl chloride
  • Patent Document 4 A method of reacting a substrate having a phenolic hydroxyl group with 5-chloro-2-pyridyl triflimide
  • Patent Document 5 a method of reacting a substrate having a phenolic hydroxyl group with 4-nitrophenyltrifluoromethanesulfon
  • Non-Patent Document 6 describes a method of reacting a metalloenolate and N-2-pyridyl triflimide, or a method of reacting a metalloenolate and N-5-chloro-2-pyridyl triflimide.
  • Non-Patent Documents 7 and 8 describe a method of reacting a ketone with trifluoromethanesulfonic anhydride.
  • An object of the present disclosure is to provide a trifluoromethanesulfonylating agent composition that can trifluoromethanesulfonylate a substrate having a functional group such as a phenolic hydroxyl group.
  • Another object of the present invention is to provide an efficient and industrially practicable method for producing a trifluoromethanesulfonyloxy compound or a trifluoromethanesulfonyl compound.
  • a trifluoromethanesulfonyloxy compound can be isolated from the reaction solution after the trifluoromethanesulfonylation reaction using only general post-treatment operations, and that a trifluoromethanesulfonyloxy compound or a trifluoromethanesulfonyl compound can be efficiently obtained. .
  • [1] Contains a compound represented by the following general formula (1) or (11), Trifluoromethanesulfonylating agent composition.
  • R 1 is a hydrogen atom, a linear alkyl group having 1 to 6 carbon atoms, or a branched alkyl group having 3 to 6 carbon atoms
  • R 2 is a hydrogen atom, a linear aliphatic hydrocarbon group having 1 to 6 carbon atoms, a branched aliphatic hydrocarbon group having 3 to 6 carbon atoms, a nitro group, an aromatic group having 6 to 14 carbon atoms
  • X is a nitrogen atom or C(R 3 )
  • Y is a nitrogen atom or C(R 4 )
  • R 3 is a hydrogen atom, a linear aliphatic hydrocarbon group having 1 to 6 carbon atoms, a branched aliphatic hydrocarbon group having 3 to 6 carbon atoms, or an aromatic hydrocarbon group having 6 to 14 carbon atoms;
  • R 3 is a hydrogen atom, a linear aliphatic hydrocarbon group having 1
  • R 2 When a plurality of R 2 exists, R 2 may be the same or different, and when a plurality of R 3 exists, R 3 may be the same or different.
  • R 5 is a hydrogen atom, a linear alkyl group having 1 to 6 carbon atoms, or a branched alkyl group having 3 to 6 carbon atoms, Z - is an anion.
  • a compound represented by the general formula (1) Any base selected from the group consisting of an aliphatic organic base, a heterocyclic group-containing organic base, and an inorganic base, The trifluoromethanesulfonylating agent composition according to [1].
  • organic base is selected from the group of secondary amines, tertiary amines, alkoxides, and organic bases having a nitrogen atom and a heterocyclic group having 4 or more carbon atoms.
  • the base is sodium carbonate, potassium carbonate, sodium bicarbonate, potassium bicarbonate, lithium methoxide, lithium ethoxide, lithium tert-butoxide, sodium methoxide, sodium ethoxide, sodium tert-butoxide, potassium methoxide, potassium ethoxy.
  • trifluoromethanesulfonylating agent composition according to any one of [2] to [5], which is selected from the group consisting of nonene.
  • Ar represents an aromatic ring group or a substituted aromatic ring group.
  • Ar represents a substituted aromatic ring group
  • the substituent of the substituted aromatic ring group is a lower alkyl group, a lower alkoxycarbonyl lower alkyl group, a ⁇ -D-glucopyranoside group, an amino group, a lower
  • R 11 , R 12 , and R 15 are a hydrogen atom, a linear alkyl group having 1 to 6 carbon atoms, or a branched alkyl group having 3 to 6 carbon atoms.
  • Xa is a nitrogen atom or C(R 13 )
  • R 13 is a hydrogen atom, a linear alkyl group having 1 to 6 carbon atoms, or a branched alkyl group having 3 to 6 carbon atoms
  • R 12 and R 13 may be combined to form a ring.
  • Z - is an anion.
  • a trifluoromethanesulfonylating agent composition that can trifluoromethanesulfonylate a substrate having a functional group such as a phenolic hydroxyl group. Furthermore, it is possible to provide an industrially practicable and efficient method for producing a trifluoromethanesulfonyloxy compound or a trifluoromethanesulfonyl compound using the above trifluoromethanesulfonylating agent composition.
  • Trifluoromethanesulfonylating agent composition contains a compound represented by the following general formula (1) or (11) as a trifluoromethanesulfonylating agent.
  • R 1 is a hydrogen atom, a linear alkyl group having 1 to 6 carbon atoms, or a branched alkyl group having 3 to 6 carbon atoms
  • R 2 is a hydrogen atom, a linear aliphatic hydrocarbon group having 1 to 6 carbon atoms, a branched aliphatic hydrocarbon group having 3 to 6 carbon atoms, a nitro group, an aromatic group having 6 to 14 carbon atoms
  • X is a nitrogen atom or C(R 3 )
  • Y is a nitrogen atom or C(R 4 )
  • R 3 is a hydrogen atom, a linear aliphatic hydrocarbon group having 1 to 6 carbon atoms, a branched aliphatic hydrocarbon group having 3 to 6 carbon atoms, or an aromatic hydrocarbon group having 6 to 14 carbon atoms
  • R 4 is a hydrogen atom, a linear aliphatic hydrocarbon group having 1 to
  • R 2 When a plurality of R 2 exists, R 2 may be the same or different, and when a plurality of R 3 exists, R 3 may be the same or different.
  • R 5 is a hydrogen atom, a linear alkyl group having 1 to 6 carbon atoms, or a branched alkyl group having 3 to 6 carbon atoms, Z - is an anion.
  • R 1 represents a hydrogen atom, a linear alkyl group having 1 to 6 carbon atoms, or a branched alkyl group having 3 to 6 carbon atoms.
  • Examples of the linear alkyl group having 1 to 6 carbon atoms include methyl group, ethyl group, n-propyl group, n-butyl group, n-pentyl group, n-hexyl group, and the like.
  • Examples of the branched alkyl group having 3 to 6 carbon atoms include isopropyl group, isobutyl group, sec-butyl group, and tert-butyl group.
  • R 1 is preferably a hydrogen atom, a methyl group, an ethyl group, an n-propyl group, or an isopropyl group because of ease of synthesis.
  • R 2 is a hydrogen atom, a linear aliphatic hydrocarbon group having 1 to 6 carbon atoms, a branched aliphatic hydrocarbon group having 3 to 6 carbon atoms, Represents a nitro group, an aromatic hydrocarbon group having 6 to 14 carbon atoms, or an aromatic heterocyclic group having 6 to 14 carbon atoms.
  • each R 2 may be the same or different.
  • Examples of the linear aliphatic hydrocarbon group having 1 to 6 carbon atoms include a linear alkyl group having 1 to 6 carbon atoms, a linear alkenyl group having 2 to 6 carbon atoms, and a linear alkenyl group having 2 to 6 carbon atoms.
  • Examples include straight-chain alkynyl groups.
  • Examples of the straight-chain alkyl group having 1 to 6 carbon atoms include those described for the straight-chain alkyl group having 1 to 6 carbon atoms as R 1 .
  • R 2 is preferably a hydrogen atom, a linear alkyl group having 1 to 6 carbon atoms, a branched alkyl group having 3 to 6 carbon atoms, or a nitro group; A linear alkyl group or a branched alkyl group having 3 to 6 carbon atoms is preferable.
  • R 2 is preferably a hydrogen atom, methyl group, ethyl group, n-propyl group, isopropyl group, or nitro group, and is a hydrogen atom, methyl group, ethyl group, n-propyl group, or isopropyl group. is more preferable.
  • X is a nitrogen atom or C(R 3 )
  • Y is a nitrogen atom or C(R 4 ).
  • R 3 is a hydrogen atom, a linear aliphatic hydrocarbon group having 1 to 6 carbon atoms, a branched aliphatic hydrocarbon group having 3 to 6 carbon atoms, or an aromatic hydrocarbon group having 6 to 14 carbon atoms; , or represents an aromatic heterocyclic group having 6 to 14 carbon atoms.
  • each R 3 may be the same or different.
  • Straight chain aliphatic hydrocarbon group having 1 to 6 carbon atoms straight chain aliphatic hydrocarbon group having 1 to 6 carbon atoms, branched aliphatic hydrocarbon group having 3 to 6 carbon atoms, aromatic hydrocarbon group having 6 to 14 carbon atoms, and 6 to 14 carbon atoms
  • aromatic heterocyclic group as R 2 include a linear aliphatic hydrocarbon group having 1 to 6 carbon atoms, a branched aliphatic hydrocarbon group having 3 to 6 carbon atoms, and a branched aliphatic hydrocarbon group having 6 to 14 carbon atoms.
  • Examples include aromatic hydrocarbon groups and aromatic heterocyclic groups having 6 to 14 carbon atoms.
  • R 3 is preferably a hydrogen atom, a linear alkyl group having 1 to 6 carbon atoms, or a branched alkyl group having 3 to 6 carbon atoms, and is preferably a hydrogen atom, a methyl group, an ethyl group, or an n- More preferably, it is a propyl group or an isopropyl group.
  • R 4 is a hydrogen atom, a linear aliphatic hydrocarbon group having 1 to 6 carbon atoms, a branched aliphatic hydrocarbon group having 3 to 6 carbon atoms, or an aromatic hydrocarbon group having 6 to 14 carbon atoms; , or represents an aromatic heterocyclic group having 6 to 14 carbon atoms.
  • each R 4 may be the same or different.
  • Straight chain aliphatic hydrocarbon group having 1 to 6 carbon atoms straight chain aliphatic hydrocarbon group having 1 to 6 carbon atoms, branched aliphatic hydrocarbon group having 3 to 6 carbon atoms, aromatic hydrocarbon group having 6 to 14 carbon atoms, and 6 to 14 carbon atoms
  • aromatic heterocyclic group as R 2 include a linear aliphatic hydrocarbon group having 1 to 6 carbon atoms, a branched aliphatic hydrocarbon group having 3 to 6 carbon atoms, and a branched aliphatic hydrocarbon group having 6 to 14 carbon atoms.
  • Examples include aromatic hydrocarbon groups and aromatic heterocyclic groups having 6 to 14 carbon atoms.
  • R 4 is preferably a hydrogen atom, a linear alkyl group having 1 to 6 carbon atoms, or a branched alkyl group having 3 to 6 carbon atoms, such as a hydrogen atom, a methyl group, an ethyl group, or an n- More preferably, it is a propyl group or an isopropyl group.
  • n is an integer from 1 to 3. It is preferable that n is 1.
  • R 5 is preferably bonded to X or Y, more preferably bonded to Y. In one preferred embodiment, R 5 combines with the nitrogen atom in X to form a cation moiety. Furthermore, in a preferred embodiment, R 5 combines with the nitrogen atom in Y to form a cation moiety.
  • Z - represents an anion.
  • Z - is preferably an anion of a strong acid or a super strong acid, such as a tetrafluoroborate anion, a hexafluorophosphate anion, a hexafluoroantimonate anion, a fluorosulfonate anion, a trifluoroacetate anion, a trifluoromethanesulfonate anion, or a fluoromethanesulfone.
  • a strong acid or a super strong acid such as a tetrafluoroborate anion, a hexafluorophosphate anion, a hexafluoroantimonate anion, a fluorosulfonate anion, a trifluoroacetate anion, a trifluoromethanesulfonate anion, or a fluoromethanesulfone.
  • the compound represented by the above general formula (11) is preferably a compound represented by the following general formula (11a).
  • the linear alkyl group having 1 to 6 carbon atoms and the branched alkyl group having 3 to 6 carbon atoms as R 11 , R 12 and R 15 include R 1 and R in the general formula (11). Examples of straight-chain alkyl groups having 1 to 6 carbon atoms and branched alkyl groups having 3 to 6 carbon atoms as R 5 and R 5 are mentioned.
  • Xa is a nitrogen atom or C(R 13 ), preferably C(R 13 ).
  • the linear alkyl group having 1 to 6 carbon atoms as R 13 and the branched alkyl group having 1 to 6 carbon atoms as R 3 in general formula (11) are Examples include chain alkyl groups and branched alkyl groups having 3 to 6 carbon atoms.
  • Z - in general formula (11a) has the same meaning as Z - in general formula (11), and preferred examples are also the same.
  • a substrate having a phenolic hydroxyl group etc. can be trifluoromethanesulfonylated.
  • a compound represented by the above general formula (1) and a compound selected from the group consisting of an aliphatic organic base, a heterocyclic group-containing organic base, and an inorganic base are preferred embodiments of the present disclosure.
  • a trifluoromethanesulfonylating agent composition comprising any one of the following bases.
  • a trifluoromethanesulfonylating agent composition (hereinafter also referred to as a first trifluoromethanesulfonylating agent composition or simply a first composition) containing a compound represented by general formula (1) and a specific base.
  • a compound represented by general formula (1) and a specific base.
  • the trifluoromethanesulfonyloxy compound can be isolated from the reaction solution after the trifluoromethanesulfonylation reaction by only general post-treatment operations, and the trifluoromethanesulfonyloxy compound can be obtained industrially and efficiently.
  • the trifluoromethanesulfonylating agent selectively reacts with respect to phenolic hydroxyl groups means that the trifluoromethanesulfonylation reaction proceeds preferentially with respect to phenolic hydroxyl groups.
  • the content of the compound represented by general formula (1) is preferably 80% or more, more preferably 90% or more, based on the total mass of the first composition.
  • the inorganic base is preferably a base selected from the group consisting of sodium salts and potassium salts, such as sodium carbonate, potassium carbonate, sodium hydrogen carbonate, potassium hydrogen carbonate, and the like. Further, hydrides of alkali metals are also preferable, and examples thereof include sodium hydride, potassium hydride, and the like.
  • Bases include sodium carbonate, potassium carbonate, sodium bicarbonate, potassium bicarbonate, lithium methoxide, lithium ethoxide, lithium tert-butoxide, sodium methoxide, sodium ethoxide, sodium tert-butoxide, potassium methoxide, potassium ethoxide. , potassium tert-butoxide, triethylamine, tri-n-propylamine, tributylamine, diisopropylethylamine, N,N-diethylcyclohexylamine, 1,8-diazabicyclo[5.4.0]undecene, and 1,5-diazabicyclo[4 .3.0] nonene is preferable.
  • sodium carbonate, potassium carbonate, sodium hydrogen carbonate, potassium hydrogen carbonate, sodium tert-butoxide, or potassium tert-butoxide is preferred, and potassium carbonate, potassium hydrogen carbonate, or potassium tert-butoxide is particularly preferred.
  • sodium carbonate, potassium carbonate, sodium hydrogen carbonate, potassium hydrogen carbonate, sodium tert-butoxide, or potassium tert-butoxide is preferred, and potassium carbonate, potassium hydrogen carbonate, or potassium tert-butoxide is particularly preferred.
  • These bases can be used alone or in combination.
  • the amount of the base to be used is not particularly limited, but it is usually preferably 0.01 to 20 mol, particularly preferably 0.05 to 5 mol, per 1 mol of the trifluoromethanesulfonyl compound to be described below.
  • the first composition of the present disclosure may further contain a solvent.
  • the solvent is not particularly limited as long as it dissolves the compound represented by the general formula (1) and the base, and examples include the reaction solvent for trifluoromethanesulfonylation described below. Note that the first composition of the present disclosure may or may not contain a solvent.
  • a method for producing a trifluoromethanesulfonyloxy compound using the first composition of the present disclosure is to convert the first trifluoromethanesulfonylating agent composition described above to the following general formula ( 2) includes a step of reacting with the compound represented by 2).
  • Ar represents an aromatic ring group or a substituted aromatic ring group.
  • Ar of the aromatic ring hydroxyl compound represented by the general formula (2) represents an aromatic ring group or a substituted aromatic ring group.
  • the aromatic ring group is not particularly limited, but may be monocyclic or polycyclic, preferably having 1 to 18 carbon atoms, such as aromatic ring groups such as phenyl group, naphthyl group, and anthryl group.
  • Ar represents an aromatic ring group, and the aromatic ring group is preferably an aromatic heterocyclic group.
  • the substituted aromatic ring group has any number of substituents and any combination of substituents on any carbon atom or nitrogen atom of the aromatic ring group.
  • substituents include halogen atoms such as fluorine, chlorine, bromine, and iodine, lower alkyl groups such as methyl, ethyl, and propyl groups, lower unsaturated groups such as vinyl, allyl, and propargyl, fluoromethyl, and chloro.
  • Lower haloalkyl groups such as methyl and bromomethyl groups, C(CF 3 ) 2 OH groups (including protected hydroxyl groups), lower alkoxy groups such as methoxy, ethoxy and propoxy groups, fluoromethoxy groups, chloromethoxy groups, and Lower haloalkoxy groups such as bromomethoxy groups, lower acyloxy groups such as formyloxy groups, acetyloxy groups, propionyloxy groups and butyryloxy groups, lower alkoxycarbonyl groups such as cyano groups, methoxycarbonyl groups, ethoxycarbonyl groups and propoxycarbonyl groups.
  • lower alkoxycarbonyl lower alkyl groups such as methoxycarbonylmethyl group, ethoxycarbonylethyl group and propoxycarbonylpropyl group, ⁇ -D-glucopyranoside group, phenyl group, naphthyl group, anthryl group, pyrrolyl group (including nitrogen-protected group), Aromatic ring groups such as pyridyl group, furyl group, thienyl group, indolyl group (including nitrogen protected groups), quinolyl group, benzofuryl group and benzothienyl group, protected forms of carboxyl groups, amino groups, protected forms of amino groups, lower These include an alkylamino group, a lower alkylamino lower alkyl group, a hydroxyl group, a protected form of a hydroxyl group, and an X'-Ar'-OH group. These substituents may be further substituted, for example, they may be further substituted by the substituents in "such substituents in
  • Ar represents a substituted aromatic ring group
  • the substituent of the substituted aromatic ring group is a lower alkyl group, a lower alkoxycarbonyl lower alkyl group, a ⁇ -D-glucopyranoside group, an amino group, a lower
  • it is an alkylamino group or a hydroxyl group.
  • X' of the X'-Ar'-OH group is a C(CH 3 ) 2 group, a C(CF 3 ) 2 group, an oxygen atom, a nitrogen atom (including a nitrogen protector), a sulfur atom, an SO group, or an SO 2 Ar' represents a phenylene group or a substituted phenylene group.
  • the substitution position of the phenylene group is the 2nd, 3rd or 4th position with respect to the hydroxyl group.
  • the substituents of the substituted phenylene group are the same as the substituents of the substituted aromatic ring group.
  • Specific examples of the aromatic hydroxyl compound represented by the general formula (2) substituted with an X'-Ar'-OH group include the following compounds.
  • the term “lower” refers to a linear or branched chain or cyclic compound having 1 to 6 carbon atoms (if the number of carbon atoms is 3 or more).
  • the aromatic ring group in the above-mentioned "such substituent” includes a halogen atom, a lower alkyl group, a lower unsaturated group, a lower haloalkyl group, a C(CF 3 ) 2 OH group (including a protected hydroxyl group), Lower alkoxy group, lower haloalkoxy group, formyloxy group, lower acyloxy group, cyano group, lower alkoxycarbonyl group, lower alkoxycarbonyl lower alkyl group, protected form of carboxyl group, protected form of amino group, hydroxyl group, hydroxyl group Protective bodies, X'-Ar'-OH groups, etc.
  • aromatic ring groups and substituted aromatic ring groups excluding "hydroxyl group”, “aromatic ring group” and “X'-Ar'-OH group” are preferable as substituents, aromatic hydrocarbon groups and substituted aromatic ring groups as substituents Particularly preferred are substituted aromatic hydrocarbon groups (aromatic hydrocarbon groups having substituents) excluding "hydroxyl group", “aromatic ring group” and "X'-Ar'-OH group”.
  • aromatic ring hydroxyl compounds having multiple hydroxyl groups multiple fluorosulfonylations may proceed depending on the reaction conditions employed.
  • One preferred embodiment includes an embodiment in which the aromatic ring hydroxyl compound represented by the above general formula (2) has at least one selected from an alcoholic hydroxyl group and an amino group as a substituent. These substituents may be further substituted, for example, they may be further substituted by the substituents in "such substituents" above.
  • the aromatic hydroxyl compound represented by the above general formula (2) is used in an amount of 0.7 mol to 1.0 mol per 1.0 mol of the trifluoromethanesulfonyl compound represented by the above general formula (1). It is preferable to use 2 mol. More preferably 0.8 mol to 1.0 mol.
  • reaction solvents for trifluoromethanesulfonylation include ether solvents, aliphatic hydrocarbon solvents, aromatic hydrocarbon solvents, halogenated hydrocarbon solvents, ester solvents, amide solvents, nitrile solvents, and sulfoxide solvents. etc.
  • reaction solvents include diethyl ether, diisopropyl ether, dibutyl ether, tert-butyl methyl ether, tetrahydrofuran, 2-methyltetrahydrofuran, tetrahydropyran, 1,4-dioxane, and cyclopentyl methyl ether. etc. can be exemplified.
  • aliphatic hydrocarbon solvents include n-hexane, n-heptane, n-pentane, n-nonane, and n-decane.
  • aromatic hydrocarbon solvents include toluene, xylene, mesitylene, and ethylbenzene.
  • halogenated hydrocarbon solvent examples include methylene chloride, chloroform, and 1,2-dichloroethane.
  • ester solvents include ethyl acetate, isopropyl acetate, n-butyl acetate, and ⁇ -butyrolactone.
  • amide solvent examples include N,N-dimethylformamide, N,N-dimethylacetamide, N-methylpyrrolidone, and 1,3-dimethyl-2-imidazolidinone.
  • nitrile solvents examples include acetonitrile, propionitrile, benzonitrile, and the like.
  • sulfoxide solvent examples include dimethyl sulfoxide and the like.
  • reaction solvents can be used alone or in combination.
  • reaction temperature The reaction temperature for trifluoromethanesulfonylation is not particularly limited, but it is preferably carried out at a reaction temperature of 150°C or lower, more preferably in the range of -100 to 150°C, and even more preferably -78 to 100°C.
  • reaction time There is no particular restriction on the reaction time for trifluoromethanesulfonylation, but it can be carried out in the range of 0.1 to 72 hours, and it varies depending on the raw materials and reaction conditions, so analytical means such as gas chromatography, liquid chromatography, NMR, etc. It is preferable to monitor the progress of the reaction and determine the end point when most of the raw materials have disappeared.
  • the post-treatment operation for isolating the trifluoromethanesulfonyloxy compound may be carried out by a general operation in organic synthesis.
  • the organic solvent for post-treatment include ether solvents, aliphatic hydrocarbon solvents, aromatic hydrocarbon solvents, halogenated hydrocarbon solvents, and ester solvents.
  • organic solvents for post-treatment include diethyl ether, diisopropyl ether, dibutyl ether, tert-butyl methyl ether, tetrahydrofuran, 2-methyltetrahydrofuran, tetrahydropyran, cyclopentyl methyl ether, n-hexane, n-heptane, n- Examples include pentane, n-nonane, n-decane, toluene, xylene, mesitylene, ethylbenzene, methylene chloride, chloroform, 1,2-dichloroethane, ethyl acetate, and n-butyl acetate.
  • ethyl acetate especially ethyl acetate.
  • the amount of the solvent used in the post-treatment may be used at least 0.05 L (liter) per mole of the trifluoromethanesulfonyl compound to be treated, and usually 0.1 to 20 L is preferable, particularly 0. .1 to 10 L is more preferable.
  • mineral acids for post-treatment include hydrochloric acid, hydrobromic acid, sulfuric acid, phosphoric acid, and nitric acid. Among them, hydrochloric acid and sulfuric acid are preferred, and hydrochloric acid is particularly preferred.
  • alkali metal salt for post-treatment include sodium hydrogen carbonate, potassium hydrogen carbonate, sodium carbonate, sodium hydroxide, potassium hydroxide, and potassium carbonate.
  • the obtained trifluoromethanesulfonyloxy compound can be appropriately and preferably used, for example, in coupling reactions using transition metals.
  • the trifluoromethanesulfonyloxy compound obtained by the first production method of the present disclosure can be isolated from the reaction solution after the reaction is completed with only a simple post-treatment operation, and therefore it is industrially suitable. It is possible to carry out the method, and as a result, the coupling reaction product can be produced much more efficiently than conventional methods.
  • Another preferred embodiment of the present disclosure includes a trifluoromethanesulfonylating agent composition containing the compound represented by the above-mentioned general formula (11).
  • a trifluoromethanesulfonylating agent composition (hereinafter also referred to as a second trifluoromethanesulfonylating agent composition or simply a second composition) containing a compound represented by general formula (11) is used to convert phenolic hydroxyl groups into It is possible to trifluoromethanesulfonylate not only the substrates possessed by the present invention but also a wide range of substrates, and trifluoromethanesulfonyl compounds derived from these substrates can be easily provided under industrially viable conditions.
  • the second composition of the present disclosure may further include a base.
  • the base include bases that can be used in the trifluoromethanesulfonylation described below. Note that the second composition of the present disclosure may or may not contain a base.
  • the amount of the base to be used is not particularly limited, but it is usually preferably 0.01 to 20 mol, particularly preferably 0.05 to 5 mol, per 1 mol of the trifluoromethanesulfonyl compound to be described below.
  • the second composition of the present disclosure may further contain a solvent.
  • the solvent is not particularly limited as long as it dissolves the compound represented by the above general formula (11) and, if the second composition contains a base, the above-mentioned base, but for example, trifluoromethane described below. Mention may be made of reaction solvents for sulfonylation. Note that the second composition of the present disclosure may or may not contain a solvent.
  • a method for producing a trifluoromethanesulfonyl compound using the second composition of the present disclosure is a method for producing a trifluoromethanesulfonyl compound using the second trifluoromethanesulfonylating agent composition described above. It includes a step of reacting with a compound.
  • Trifluoromethanesulfonyl compound Compounds to be trifluoromethanesulfonylated with the second trifluoromethanesulfonylating agent composition (hereinafter also referred to as trifluoromethanesulfonyl compounds) include compounds having a phenolic hydroxyl group, compounds having an alcoholic hydroxyl group, and ketones.
  • the substrate is preferably at least one selected from the group consisting of , primary amines, and secondary amines.
  • Examples of the compound having a phenolic hydroxyl group include aromatic hydroxyl compounds represented by the above-mentioned general formula (2).
  • Examples of compounds having alcoholic hydroxyl groups include alkyl alcohols having 1 to 20 carbon atoms, methyl lactate, phenylethyl alcohol, and tetraacetyl- ⁇ -D-mannose.
  • ketone examples include ethyl acetoacetate, acetylacetone, cyclohexanone, 1,3-cyclohexanedione, and ethyl 2-oxocyclohexanecarboxylate.
  • Examples of primary amines include alkylamines having 1 to 20 carbon atoms, aniline, 1-phenylethylamine, and ⁇ -amino acids.
  • Examples of the secondary amine include alkylamines having 1 to 20 carbon atoms, methylaniline, N-methylphenylethylamine, piperidine, and the like.
  • trifluoromethanesulfonyl compound having not only one functional group but also two or three functional groups in one molecule can be converted into trifluoromethane by the second trifluoromethanesulfonylating agent composition of the present disclosure. Sulfonylation is possible. In a trifluoromethanesulfonyl compound having multiple functional groups, multiple fluorosulfonylations may proceed depending on the reaction conditions employed.
  • the trifluoromethanesulfonyl compound and the second trifluoromethanesulfonylating agent composition of the present disclosure are brought into contact and trifluoromethanesulfonylated, the trifluoromethanesulfonyl compound and the trifluoromethanesulfonylating agent (
  • reaction solvents for trifluoromethanesulfonylation include ether solvents, aliphatic hydrocarbon solvents, aromatic hydrocarbon solvents, halogenated hydrocarbon solvents, ester solvents, amide solvents, nitrile solvents, and sulfoxide solvents. etc.
  • reaction solvents include those described in the reaction solvent in the above-mentioned first production method, and preferred examples are also the same.
  • reaction solvent used for trifluoromethanesulfonylation there is no particular restriction on the amount of the reaction solvent used for trifluoromethanesulfonylation, but it may be used at least 0.05 L (liter) per mole of the trifluoromethanesulfonyl compound, and usually 0.1 to 20 L is preferable. , particularly preferably 0.1 to 10 L.
  • the above trifluoromethanesulfonylation reaction is preferably carried out using a base.
  • the base include the bases described above as bases that can be included in the first composition.
  • triethylamine, sodium hydride, diisopropylethylamine, tributylamine, pyridine, 2,3-lutidine, 2,4-lutidine, 2,5-lutidine, 2,6-lutidine, 3,4-lutidine, 3, 5-lutidine is preferred, and triethylamine and sodium hydride are more preferred.
  • the amount of the base to be used is not particularly limited, but it is usually preferably 0.01 to 20 mol, particularly preferably 0.05 to 5 mol, per 1 mol of the trifluoromethanesulfonyl compound to be described below.
  • reaction temperature The reaction temperature for trifluoromethanesulfonylation is not particularly limited, but it is preferably carried out at a reaction temperature of 150°C or lower, more preferably in the range of -100 to 150°C, and even more preferably -78 to 100°C.
  • reaction time There is no particular restriction on the reaction time for trifluoromethanesulfonylation, but it can be carried out in the range of 0.1 to 72 hours, and it varies depending on the raw materials and reaction conditions, so analytical means such as gas chromatography, liquid chromatography, NMR, etc. It is preferable to monitor the progress of the reaction and determine the end point when most of the raw materials have disappeared.
  • the post-treatment operation for isolating the trifluoromethanesulfonyl compound may be carried out by a general operation in organic synthesis.
  • the organic solvent for post-treatment include ether solvents, aliphatic hydrocarbon solvents, aromatic hydrocarbon solvents, halogenated hydrocarbon solvents, and ester solvents.
  • organic solvent for post-treatment examples include the specific examples described in the above-mentioned organic solvent for post-treatment in the first production method, and preferred examples are also the same.
  • Organic solvents can be used alone or in combination.
  • the amount of the solvent used in the post-treatment may be used at least 0.05 L (liter) per mole of the trifluoromethanesulfonyl compound to be treated, and usually 0.1 to 20 L is preferable, particularly 0. .1 to 10 L is more preferable.
  • mineral acid and alkali metal salt for post-treatment include the specific examples described in the above-mentioned mineral acid and alkali metal salt for post-treatment in the first production method, and preferred examples are also the same.
  • the trifluoromethanesulfonyl compound obtained by the second production method of the present disclosure can be isolated from the reaction solution after the reaction is completed with only a simple post-treatment operation, and can be industrially implemented. and can be manufactured efficiently.
  • the yield (%) is a value obtained by measurement of nuclear magnetic resonance spectrum 19F -NMR.
  • Synthesis Examples 1 to 3 and Examples 1 to 27 are based on the first embodiment using a trifluoromethanesulfonylating agent composition containing the compound represented by the above general formula (1) and a specific base. handle. Furthermore, Synthesis Examples 4 to 7 and Examples 28 to 35 correspond to the second embodiment using a trifluoromethanesulfonylating agent composition containing the compound represented by the above-mentioned general formula (11).
  • reaction solution When a small amount of the reaction solution was concentrated and analyzed by 1 H-NMR, the signal derived from imidazole completely disappeared, and a new signal derived from 1-trifluoromethanesulfonylimidazole was observed.
  • Example 1 195 mg (1.00 mmol, 1.0 eq.) of L-tyrosine methyl ester as a substrate and 5 mL of acetonitrile as a reaction solvent were collected and charged into a 20 mL Schlenk tube containing a stirrer as a reactor. Subsequently, a composition containing 220 mg (1.10 mmol, 1.1 eq.) of 1-trifluoromethanesulfonylimidazole and 28 mg (0.20 mmol, 0.2 eq.) of potassium carbonate was added to the reactor and stirred at room temperature for 2 hours. A reaction solution was obtained.
  • Example 2 196 mg (1.00 mmol, 1.0 eq.) of L-tyrosine methyl ester as a substrate and 5 mL of dimethylformamide (DMF) as a reaction solvent were collected and charged into a Schlenk tube with a capacity of 20 mL and a stirrer, which was a reactor. Subsequently, a composition containing 228 mg (1.14 mmol, 1.1 eq.) of 1-trifluoromethanesulfonylimidazole and 27 mg (0.20 mmol, 0.2 eq.) of potassium carbonate was added to the reactor, and the mixture was stirred at room temperature for 2 hours. A reaction solution was obtained.
  • DMF dimethylformamide
  • Example 3 197 mg (1.01 mmol, 1.0 eq.) of L-tyrosine methyl ester as a substrate and 5 mL of dimethyl sulfoxide (DMSO) as a reaction solvent were collected and charged into a Schlenk tube with a capacity of 20 mL and a stirrer, which was a reactor. Subsequently, a composition containing 228 mg (1.14 mmol, 1.1 eq.) of 1-trifluoromethanesulfonylimidazole and 28 mg (0.20 mmol, 0.2 eq.) of potassium carbonate was added to the reactor, and the mixture was stirred at room temperature for 2 hours. A reaction solution was obtained.
  • DMSO dimethyl sulfoxide
  • Example 4 196 mg (1.00 mmol, 1.0 eq.) of L-tyrosine methyl ester as a substrate and 5 mL of gamma-butyrolactone as a reaction solvent were collected and charged into a 20 mL Schlenk tube containing a stirrer, which was a reactor. Subsequently, a composition containing 223 mg (1.12 mmol, 1.1 eq.) of 1-trifluoromethanesulfonylimidazole and 27 mg (0.20 mmol, 0.2 eq.) of potassium carbonate was added to the reactor, and the mixture was stirred at room temperature for 2 hours. A reaction solution was obtained.
  • Example 5 586 mg (3.00 mmol, 1.0 eq.) of L-tyrosine methyl ester as a substrate and 15 mL of tetrahydrofuran (THF) as a reaction solvent were collected and charged into a 50 mL two-necked flask containing a stirrer, which was a reactor. Subsequently, a composition containing 720 mg (3.60 mmol, 1.2 eq.) of 1-trifluoromethanesulfonylimidazole and 67 mg (0.60 mmol, 0.2 eq.) of potassium tert-butoxide was added to the reactor, and the mixture was heated at room temperature for 16 hours.
  • THF tetrahydrofuran
  • Example 6 196 mg (1.01 mmol, 1.0 eq.) of L-tyrosine methyl ester as a substrate and 5 mL of acetonitrile as a reaction solvent were collected and charged into a Schlenk tube with a capacity of 20 mL and a stirrer, which was a reactor. Subsequently, a composition containing 222 mg (1.11 mmol, 1.1 eq.) of 1-trifluoromethanesulfonylimidazole and 51 mg (0.52 mmol, 0.5 eq.) of triethylamine was added to the reactor and stirred at room temperature for 20 hours. A reaction solution was obtained.
  • Example 7 111 mg (1.02 mmol, 1.0 eq.) of 4-aminophenol as a substrate and 5 mL of acetonitrile as a reaction solvent were collected and charged into a Schlenk tube with a capacity of 20 mL and a stirrer, which was a reactor. Subsequently, a composition containing 222 mg (1.11 mmol, 1.1 eq.) of 1-trifluoromethanesulfonylimidazole and 28 mg (0.20 mmol, 0.2 eq.) of potassium carbonate was added to the reactor, and the mixture was stirred at room temperature for 2 hours. A reaction solution was obtained.
  • Example 8 109 mg (1.00 mmol, 1.0 eq.) of 2-aminophenol as a substrate and 5 mL of acetonitrile as a reaction solvent were collected and charged into a Schlenk tube with a capacity of 20 mL and a stirrer, which was a reactor. Subsequently, a composition containing 202 mg (1.01 mmol, 1.0 eq.) of 1-trifluoromethanesulfonylimidazole and 29 mg (0.21 mmol, 0.2 eq.) of potassium carbonate was added to the reactor, and the mixture was stirred at room temperature for 3 hours. A reaction solution was obtained.
  • Example 9 1.08 g (7.87 mmol, 1.0 eq.) of 4-(2-aminoethyl)phenol as a substrate and 39 mL of tetrahydrofuran as a reaction solvent were collected and charged into a Schlenk tube with a capacity of 20 mL and a stir bar as a reactor. is. Subsequently, a composition containing 1.89 g (9.44 mmol, 1.2 eq.) of 1-trifluoromethanesulfonylimidazole and 177 mg (1.58 mmol, 0.2 eq.) of potassium tert-butoxide was added to the reactor, and the mixture was heated to room temperature.
  • Example 10 276 mg (2.00 mmol, 1.0 eq.) of 2-(4-hydroxyphenyl)ethanol as a substrate and 10 mL of acetonitrile as a reaction solvent were collected and charged into a Schlenk tube with a capacity of 20 mL and a stirrer, which was a reactor. Subsequently, a composition containing 401 mg (2.00 mmol, 1.0 eq.) of 1-trifluoromethanesulfonylimidazole and 14 mg (0.10 mmol, 0.05 eq.) of potassium carbonate was added to the reactor, and the mixture was stirred at room temperature for 22 hours. A reaction solution was obtained.
  • Example 11 139 mg (1.00 mmol, 1.0 eq.) of 2-(4-hydroxyphenyl)ethanol as a substrate and 5 mL of acetonitrile as a reaction solvent were collected and charged into a Schlenk tube with a capacity of 20 mL and a stirrer, which was a reactor. Subsequently, a composition containing 202 mg (1.01 mmol, 1.0 eq.) of 1-trifluoromethanesulfonylimidazole and 20 mg (0.20 mmol, 0.2 eq.) of potassium hydrogen carbonate was added to the reactor, and the mixture was heated at room temperature for 30 hours. The mixture was stirred to obtain a reaction solution.
  • Example 12 335 mg (2.00 mmol, 1.0 eq.) of L-phenylephrine as a substrate and 10 mL of dimethylformamide as a reaction solvent were collected and charged into a 20 mL Schlenk tube containing a stirrer, which was a reactor. Subsequently, a composition containing 400 mg (2.00 mmol, 1.0 eq.) of 1-trifluoromethanesulfonylimidazole and 14 mg (0.10 mmol, 0.05 eq.) of potassium carbonate was added to the reactor and stirred at room temperature for 5 hours. A reaction solution was obtained.
  • Example 13 167 mg (1.00 mmol, 1.0 eq.) of L-phenylephrine as a substrate and 5 mL of dimethylformamide as a reaction solvent were collected and charged into a Schlenk tube with a capacity of 20 mL and a stirrer, which was a reactor. Subsequently, a composition containing 201 mg (1.00 mmol, 1.0 eq.) of 1-trifluoromethanesulfonylimidazole and 20 mg (0.20 mmol, 0.2 eq.) of potassium hydrogen carbonate was added to the reactor, and the mixture was heated at room temperature for 22 hours. The mixture was stirred to obtain a reaction solution.
  • Example 14 666 mg (5.00 mmol, 1.0 eq.) of 5-hydroxyindole as a substrate and 10 mL of acetonitrile as a reaction solvent were collected and charged into a 20 mL Schlenk tube containing a stirrer, which was a reactor. Subsequently, a composition containing 1.00 g (5.00 mmol, 1.0 eq.) of 1-trifluoromethanesulfonylimidazole and 138 mg (1.00 mmol, 0.2 eq.) of potassium carbonate was added to the reactor, and the mixture was heated at room temperature. The mixture was stirred for hours to obtain a reaction solution.
  • Example 15 134 mg (1.00 mmol, 1.0 eq.) of 6-hydroxyindazole as a substrate and 5 mL of acetonitrile as a reaction solvent were collected and charged into a Schlenk tube with a capacity of 20 mL and a stirrer, which was a reactor. Subsequently, a composition containing 201 mg (1.01 mmol, 1.0 eq.) of 1-trifluoromethanesulfonylimidazole and 27 mg (0.19 mmol, 0.2 eq.) of potassium carbonate was added to the reactor, and the mixture was stirred at room temperature for 2 hours. A reaction solution was obtained.
  • Example 16 500 mg (2.73 mmol, 1.0 eq.) of 4-hydroxycarbazole as a substrate and 5.4 mL of acetonitrile as a reaction solvent were collected and charged into a 20 mL Schlenk tube containing a stirrer as a reactor. Subsequently, a composition containing 550 mg (2.75 mmol, 1.0 eq.) of 1-trifluoromethanesulfonylimidazole and 75 mg (0.54 mmol, 0.2 eq.) of potassium carbonate was added to the reactor and stirred at room temperature for 4 hours. A reaction solution was obtained.
  • Example 17 96 mg (1.0 mmol, 1.0 eq.) of 4-hydroxypyridine as a substrate and 5 mL of tetrahydrofuran as a reaction solvent were collected and charged into a Schlenk tube with a capacity of 20 mL and a stirrer, which was a reactor. Subsequently, a composition containing 244 mg (1.22 mmol, 1.2 eq.) of 1-trifluoromethanesulfonylimidazole and 22 mg (0.20 mmol, 0.2 eq.) of potassium tert-butoxide was added to the reactor, and the mixture was heated at 70°C. The mixture was stirred for 5 hours to obtain a reaction solution.
  • Example 18 671 mg (5.00 mmol, 1.0 eq.) of pyrrolo[2,3-b]pyridin-5-ol as a substrate and 25 mL of tetrahydrofuran as a reaction solvent were collected and placed in a 2-neck reactor with a 50 mL capacity and a stirring bar. I put it in a flask. Subsequently, a composition containing 1.20 g (6.00 mmol, 1.2 eq.) of 1-trifluoromethanesulfonylimidazole and 112 mg (1.00 mmol, 0.2 eq.) of potassium tert-butoxide was added to the reactor, and the mixture was heated to room temperature.
  • Example 19 169 mg (1.01 mmol, 1.0 eq.) of methyl 2,4-dihydroxybenzoate as a substrate and 5 mL of acetonitrile as a reaction solvent were collected and charged into a Schlenk tube with a capacity of 20 mL and a stirrer, which was a reactor. Subsequently, a composition containing 202 mg (1.01 mmol, 1.0 eq.) of 1-trifluoromethanesulfonylimidazole and 28 mg (0.20 mmol, 0.2 eq.) of potassium carbonate was added to the reactor and stirred at room temperature for 7 hours. A reaction solution was obtained.
  • Example 20 544 mg (2.00 mmol, 1.0 eq.) of arbutin as a substrate and 10 mL of dimethylformamide as a reaction solvent were collected and charged into a Schlenk tube with a capacity of 20 mL and a stirrer, which was a reactor. Subsequently, a composition containing 400 mg (2.00 mmol, 1.0 eq.) of 1-trifluoromethanesulfonylimidazole and 14 mg (0.10 mmol, 0.05 eq.) of potassium carbonate was added to the reactor and stirred at room temperature for 5 hours. A reaction solution was obtained.
  • Example 21 273 mg (1.00 mmol, 1.0 eq.) of arbutin as a substrate and 5 mL of dimethylformamide as a reaction solvent were collected and charged into a Schlenk tube with a capacity of 20 mL and a stirrer, which was a reactor. Subsequently, a composition containing 201 mg (1.00 mmol, 1.0 eq.) of 1-trifluoromethanesulfonylimidazole and 19 mg (0.19 mmol, 0.2 eq.) of potassium hydrogen carbonate was added to the reactor, and the mixture was heated at room temperature for 22 hours. The mixture was stirred to obtain a reaction solution.
  • Example 22 112 mg (1.03 mmol, 1.0 eq.) of 4-aminophenol as a substrate and 5 mL of acetonitrile as a reaction solvent were collected and charged into a 20 mL Schlenk tube containing a stirrer, which was a reactor. Subsequently, a composition containing 238 mg (1.11 mmol, 1.1 eq.) of 2-methyl-1-trifluoromethanesulfonylimidazole and 27 mg (0.19 mmol, 0.2 eq.) of potassium carbonate was added to the reactor, and the mixture was heated to room temperature. The mixture was stirred for 20 hours to obtain a reaction solution.
  • Example 24 (First reaction) 111 mg (1.02 mmol, 1.0 eq.) of 4-aminophenol as a substrate and 5 mL of acetonitrile as a reaction solvent were collected and charged into a Schlenk tube with a capacity of 20 mL and a stirrer, which was a reactor. Subsequently, a composition containing 222 mg (1.11 mmol, 1.1 eq.) of 1-trifluoromethanesulfonylimidazole and 28 mg (0.20 mmol, 0.2 eq.) of potassium carbonate was added to the reactor, and the mixture was stirred at room temperature for 2 hours. A reaction solution was obtained.
  • the reactor was sealed and stirred at 60°C for 20 hours to obtain a reaction solution. After adding 20 mL of ethyl acetate to the reaction solution and washing with 20 mL of clean water, the organic phase was dried over sodium sulfate and concentrated under reduced pressure. When 1,4-bis(trifluoromethyl)benzene was added as an internal standard to the resulting residue and analyzed by 1 H-NMR, a signal originating from 4-(4-methylphenyl)aniline was confirmed, and its quantitative yield was confirmed. The rate was 99%.
  • Example 25 (First reaction) 196 mg (1.01 mmol, 1.0 eq.) of L-tyrosine methyl ester as a substrate and 5 mL of acetonitrile as a reaction solvent were collected and charged into a Schlenk tube with a capacity of 20 mL and a stirrer, which was a reactor. Subsequently, a composition containing 223 mg (1.11 mmol, 1.1 eq.) of 1-trifluoromethanesulfonylimidazole and 28 mg (0.20 mmol, 0.2 eq.) of potassium carbonate was added to the reactor and stirred at room temperature for 2 hours. A reaction solution was obtained.
  • Nitrogen bubbling was performed in the obtained solution for 15 minutes, and 62 mg (54 ⁇ mol, 0.05 eq.) of tetrakis(triphenylphosphine)palladium, 15 mg (77 ⁇ mol, 0.08 eq.) of copper iodide, and 4-ethynyl were added under a nitrogen stream. 179 mg (1.54 mmol, 1.5 eq.) of toluene was collected and added to the reactor. The reactor was sealed and stirred at 80°C for 20 hours to obtain a reaction solution. After adding 30 mL of ethyl acetate to the reaction solution and washing with 30 mL of clean water, the organic phase was dried over sodium sulfate and concentrated under reduced pressure.
  • Example 25 The first reaction and second reaction in Example 25 are shown below. First reaction Same as Example 23. Second reaction
  • Example 26 The first reaction and second reaction in Example 26 are shown below. First reaction Same as Example 23. Second reaction
  • Example 27 (First reaction) 195 mg (1.00 mmol, 1.0 eq.) of L-tyrosine methyl ester as a substrate and 5 mL of acetonitrile as a reaction solvent were collected and charged into a 20 mL Schlenk tube containing a stirrer as a reactor. Subsequently, a composition containing 221 mg (1.10 mmol, 1.1 eq.) of 1-trifluoromethanesulfonylimidazole and 27 mg (0.20 mmol, 0.2 eq.) of potassium carbonate was added to the reactor, and the mixture was stirred at room temperature for 2 hours. A reaction solution was obtained.
  • Example 27 The first reaction and second reaction in Example 27 are shown below. First reaction Same as Example 23. Second reaction
  • the reactor was stirred for 1 hour while being cooled to -20°C to obtain a reaction solution.
  • benzotrifluoride was added as an internal standard to the reaction solution and analyzed by 19 F-NMR, a signal derived from indol-5-yltrifluoromethanesulfonate was confirmed at -74 ppm, and the quantitative yield was 22%.
  • one type of signal derived from a by-product was observed at -73 ppm, and the quantitative yield was 29%.
  • the reactor was cooled with dry ice, and 10.6 g (69.4 mmol, 1.0 eq.) of trifluoromethanesulfonyl fluoride was charged from a bomb. The reactor was returned to room temperature and stirred for 18 hours to obtain a reaction solution.
  • benzotrifluoride was added as an internal standard to the reaction solution and analyzed by 19 F-NMR, a signal derived from 4-(2-hydroxyethyl)phenyltrifluoromethanesulfonate was confirmed at -74 ppm, and the quantitative yield was 33%. Met.
  • two types of signals derived from by-products were observed at -74 ppm, and the yields were 15% and 11%, respectively.
  • the trifluoromethanesulfonylated compound can be obtained in good yield while suppressing the production of by-products.
  • the phenolic hydroxyl group can be selectively trifluoromethanesulfonylated.
  • reaction 1 When a small amount of the reaction solution was concentrated and analyzed by 1 H-NMR, the signal derived from 2-methylimidazole completely disappeared, and a new signal derived from trifuryl-2-methylimidazole was observed. It was confirmed that reaction 1 was completed.
  • Example 28 93 mg (1.0 mmol, 1.0 eq.) of aniline as a substrate and 5 mL of acetonitrile as a reaction solvent were collected and charged into a 20 mL Schlenk tube containing a stirrer, which was a reactor. While cooling the Schlenk tube in an ice bath, add both components: 0.95 g (2.5 mmol, 2.5 eq.) of triflyl-2,3-dimethylimidazolium triflate and 51 mg (0.5 mmol, 0.5 eq.) of triethylamine. A further composition containing was added into the Schlenk tube. After removing the ice bath, the mixture was stirred at room temperature for 2 hours to obtain a reaction solution. When benzotrifluoride was added as an internal standard to the reaction solution and analyzed by 19 F-NMR, a signal derived from N-phenyltrifluimide was confirmed at -71 ppm, and the quantitative yield was 98%.
  • Example 29 73 mg (1.0 mmol, 1.0 eq.) of butylamine as a substrate and 5 mL of acetonitrile were collected and charged into a 20 mL Schlenk tube containing a stirrer, which was a reactor. While cooling the Schlenk tube in an ice bath, add both components: 0.95 g (2.5 mmol, 2.5 eq.) of triflyl-2,3-dimethylimidazolium triflate and 51 mg (0.5 mmol, 0.5 eq.) of triethylamine. Further compositions were added into the Schlenk tube. After removing the ice bath, the mixture was stirred at room temperature for 24 hours to obtain a reaction solution.
  • Example 30 0.12 g (1.0 mmol, 1.0 eq.) of 1-phenylethylamine as a substrate and 5 mL of acetonitrile were collected and charged into a Schlenk tube with a capacity of 20 mL and a stirrer, which was a reactor. While cooling the Schlenk tube in an ice bath, add both components: 0.95 g (2.5 mmol, 2.5 eq.) of triflyl-2,3-dimethylimidazolium triflate and 51 mg (0.5 mmol, 0.5 eq.) of triethylamine. Further compositions were added into the Schlenk tube.
  • Example 31 0.15 g (1.0 mmol, 1.0 eq.) of 6-isopropyl-3-methylphenol as a substrate and 5 mL of acetonitrile were collected and charged into a 20 mL Schlenk tube containing a stirrer, which was a reactor. While cooling the Schlenk tube in an ice bath, add both components: 0.57 g (1.5 mmol, 1.5 eq.) of triflyl-2,3-dimethylimidazolium triflate and 51 mg (0.5 mmol, 0.5 eq.) of triethylamine. Further compositions were added into the Schlenk tube. After removing the ice bath, the mixture was stirred at room temperature for 2 hours to obtain a reaction solution.
  • Example 32 0.31 g (3.0 mmol, 1.0 eq.) of methyl lactate as a substrate and 15 mL of acetonitrile were collected and charged into a 30 mL two-necked flask containing a stirrer. While cooling the two-necked flask in an ice bath, add both components: 1.70 g (4.5 mmol, 1.5 eq.) of triflyl-2,3-dimethylimidazolium triflate and 91 mg (0.9 mmol, 0.3 eq.) of triethylamine. A composition containing the following was further added into the two-necked flask.
  • Example 33 0.33 g (2.5 mmol, 1.0 eq.) of ethyl acetoacetate as a substrate, 12.5 mL of tetrahydrofuran as a reaction solvent, and 0.10 g (2.5 mmol) of sodium hydride (60% by mass oil dispersion). , 1.0 eq.) was collected and charged into a 30 mL two-necked flask containing a stirrer, and then stirred at room temperature for 10 minutes.
  • Example 34 93 mg (1.0 mmol, 1.0 eq.) of aniline as a substrate and 5 mL of acetonitrile were collected and charged into a Schlenk tube with a capacity of 20 mL and a stirrer, which was a reactor. While cooling the Schlenk tube in an ice bath, prepare a composition containing both 0.91 g (2.5 mmol, 2.5 eq.) of trifuryl-3-methylimidazolium triflate and 51 mg (0.5 mmol, 0.5 eq.) of triethylamine. Additional material was added into the Schlenk tube. The ice bath was removed, and the mixture was stirred at room temperature for 1 hour to obtain a reaction solution. When benzotrifluoride was added to the reaction solution as an internal standard and analyzed by 19 F-NMR, a signal derived from N-phenyltrifluimide was confirmed at -71 ppm, and the quantitative yield was 93%.
  • Example 35 47 mg (0.5 mmol, 1.0 eq.) of aniline as a substrate and 2.5 mL of acetonitrile were collected and charged into a Schlenk tube with a capacity of 20 mL and a stirrer, which was a reactor. While cooling the Schlenk tube in an ice bath, add 0.49 g (1.3 mmol, 2.5 eq.) of trifuryl-3-ethyl-2-methylimidazolium triflate synthesized by the method described in Example 4 and 25 mg (0.2 mmol, 2.5 eq.) of triethylamine. .25 mmol, 0.5 eq.) of the composition containing both components was further added into the Schlenk tube.
  • the trifluoromethanesulfonylating agent composition of the present disclosure can be used as a trifluoromethanesulfonylating agent composition under industrially practicable conditions in the synthesis of drug substances or intermediates for pharmaceuticals.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PCT/JP2023/016923 2022-05-02 2023-04-28 トリフルオロメタンスルホニル化剤組成物、及び、トリフルオロメタンスルホニルオキシ化合物またはトリフルオロメタンスルホニル化合物の製造方法 Ceased WO2023214552A1 (ja)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP23799482.7A EP4506334A4 (en) 2022-05-02 2023-04-28 Composition of a trifluoromethane sulfonylation agent and process for producing a trifluoromethane sulfonylox compound or a trifluoromethane sulfonyl compound
US18/862,440 US20250289781A1 (en) 2022-05-02 2023-04-28 Trifluoromethanesulfonylating agent composition and method for producing trifluoromethanesulfonyloxy compound or trifluoromethanesulfonyl compound
JP2024519216A JPWO2023214552A1 (cg-RX-API-DMAC7.html) 2022-05-02 2023-04-28
CN202380037379.0A CN119137096A (zh) 2022-05-02 2023-04-28 三氟甲磺酰化剂组合物、以及三氟甲磺酰氧基化合物或三氟甲磺酰化合物的制造方法

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2022-076302 2022-05-02
JP2022076302 2022-05-02

Publications (1)

Publication Number Publication Date
WO2023214552A1 true WO2023214552A1 (ja) 2023-11-09

Family

ID=88646489

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2023/016923 Ceased WO2023214552A1 (ja) 2022-05-02 2023-04-28 トリフルオロメタンスルホニル化剤組成物、及び、トリフルオロメタンスルホニルオキシ化合物またはトリフルオロメタンスルホニル化合物の製造方法

Country Status (5)

Country Link
US (1) US20250289781A1 (cg-RX-API-DMAC7.html)
EP (1) EP4506334A4 (cg-RX-API-DMAC7.html)
JP (1) JPWO2023214552A1 (cg-RX-API-DMAC7.html)
CN (1) CN119137096A (cg-RX-API-DMAC7.html)
WO (1) WO2023214552A1 (cg-RX-API-DMAC7.html)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025094700A1 (ja) * 2023-11-01 2025-05-08 学校法人神戸薬科大学 トリフルオロメタンスルホニル化剤組成物、及び、トリフルオロメタンスルホニルオキシ化合物の製造方法
WO2025150497A1 (ja) * 2024-01-12 2025-07-17 学校法人神戸薬科大学 トリフルオロメタンスルホンアミド化合物の製造方法
WO2025173780A1 (ja) * 2024-02-16 2025-08-21 中外製薬株式会社 スルホニルトリアゾリウムを用いるスルホンアミド化合物の製造方法

Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09286771A (ja) * 1996-04-23 1997-11-04 Central Glass Co Ltd トリフルオロメタンスルホンアニリド誘導体の製造方法
JP2002128752A (ja) 2000-10-24 2002-05-09 Central Glass Co Ltd ビナフトールのビストリフレート体の製造方法
JP2003286244A (ja) * 2002-03-27 2003-10-10 Yakult Honsha Co Ltd N−フェニルビス(トリフルオロメタンスルホンイミド)の製造方法
WO2007073503A2 (en) 2005-12-21 2007-06-28 Bristol-Myers Squibb Company Indane modulators of glucocorticoid receptor, ap-1, and/or nf-kb activity and use thereof
JP2011515379A (ja) * 2008-03-19 2011-05-19 サントル ナスィオナル ド ラ ルシェルシュ スィアンティフィク ホウ素又はアルミニウム錯体
WO2011095625A1 (en) 2010-02-05 2011-08-11 Heptares Therapeutics Limited 1,2,4-triazine-4-amine derivatives
WO2013044092A1 (en) 2011-09-21 2013-03-28 Amgen Inc. Amino-oxazines and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use
WO2014190271A2 (en) 2013-05-24 2014-11-27 Alkermes Pharma Ireland Limted Methods for treating depressive symptoms
CN104230960A (zh) 2013-06-06 2014-12-24 山东轩竹医药科技有限公司 四并环类间变性淋巴瘤激酶抑制剂
JP2019156781A (ja) * 2018-03-14 2019-09-19 旭化成株式会社 イミダゾリドの製造方法
CN111187219A (zh) * 2020-02-28 2020-05-22 马鞍山南大高新技术研究院有限公司 一种磺酰胺咪唑盐化合物及其制备方法和应用
JP2022076302A (ja) 2020-11-09 2022-05-19 富士通株式会社 半導体装置、半導体装置の製造方法及び電子装置

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118878466A (zh) * 2020-01-31 2024-11-01 特里纳普克公司 三氟唑及其制备方法

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09286771A (ja) * 1996-04-23 1997-11-04 Central Glass Co Ltd トリフルオロメタンスルホンアニリド誘導体の製造方法
JP2002128752A (ja) 2000-10-24 2002-05-09 Central Glass Co Ltd ビナフトールのビストリフレート体の製造方法
JP2003286244A (ja) * 2002-03-27 2003-10-10 Yakult Honsha Co Ltd N−フェニルビス(トリフルオロメタンスルホンイミド)の製造方法
WO2007073503A2 (en) 2005-12-21 2007-06-28 Bristol-Myers Squibb Company Indane modulators of glucocorticoid receptor, ap-1, and/or nf-kb activity and use thereof
JP2011515379A (ja) * 2008-03-19 2011-05-19 サントル ナスィオナル ド ラ ルシェルシュ スィアンティフィク ホウ素又はアルミニウム錯体
WO2011095625A1 (en) 2010-02-05 2011-08-11 Heptares Therapeutics Limited 1,2,4-triazine-4-amine derivatives
WO2013044092A1 (en) 2011-09-21 2013-03-28 Amgen Inc. Amino-oxazines and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use
WO2014190271A2 (en) 2013-05-24 2014-11-27 Alkermes Pharma Ireland Limted Methods for treating depressive symptoms
CN104230960A (zh) 2013-06-06 2014-12-24 山东轩竹医药科技有限公司 四并环类间变性淋巴瘤激酶抑制剂
JP2019156781A (ja) * 2018-03-14 2019-09-19 旭化成株式会社 イミダゾリドの製造方法
CN111187219A (zh) * 2020-02-28 2020-05-22 马鞍山南大高新技术研究院有限公司 一种磺酰胺咪唑盐化合物及其制备方法和应用
JP2022076302A (ja) 2020-11-09 2022-05-19 富士通株式会社 半導体装置、半導体装置の製造方法及び電子装置

Non-Patent Citations (11)

* Cited by examiner, † Cited by third party
Title
"Protective Groups in Organic Synthesis", 1999, JOHN WILEY & SONS,INC.
D.L.COMINS ET AL., TETRAHEDRON LETTERS, vol. 42, 1992, pages 6299 - 6302
D.XI, EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, vol. 178, 2019, pages 802 - 817
EFFENBERGER, F. AND MACK, K.E.: "Trifluoromethanesulfonic imidazolide. A convenient reagent for introducing the triflate group", TETRAHEDRON LETTERS, ELSEVIER, AMSTERDAM , NL, vol. 45., 1 January 1970 (1970-01-01), Amsterdam , NL , pages 3947/3948., XP002110026, ISSN: 0040-4039, DOI: 10.1016/S0040-4039(01)98633-2 *
J.B; HENDRICKSON. ET AL., TETRAHEDRON LETTERS, vol. 46, 1973, pages 4607 - 4610
J.E.MCMURRY ET AL., TETRAHEDRON LETTERS, vol. 10, 1983, pages 979 - 982
M.LESPERANCE ET AL., STEROIDS, vol. 140, 2018, pages 104 - 113
M.TRANCHANT ET AL., TETRAHEDRON, vol. 58, 2002, pages 8425 - 8432
P.J.STANG ET AL., SYNTHESIS, vol. 4, 1980, pages 283 - 284
P.KANCHARLA ET AL., JOURNAL OF MEDICIAL CHEMISTRY, vol. 63, 2020, pages 6179 - 6202
See also references of EP4506334A4

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025094700A1 (ja) * 2023-11-01 2025-05-08 学校法人神戸薬科大学 トリフルオロメタンスルホニル化剤組成物、及び、トリフルオロメタンスルホニルオキシ化合物の製造方法
WO2025150497A1 (ja) * 2024-01-12 2025-07-17 学校法人神戸薬科大学 トリフルオロメタンスルホンアミド化合物の製造方法
WO2025173780A1 (ja) * 2024-02-16 2025-08-21 中外製薬株式会社 スルホニルトリアゾリウムを用いるスルホンアミド化合物の製造方法

Also Published As

Publication number Publication date
EP4506334A4 (en) 2026-04-22
CN119137096A (zh) 2024-12-13
JPWO2023214552A1 (cg-RX-API-DMAC7.html) 2023-11-09
US20250289781A1 (en) 2025-09-18
EP4506334A1 (en) 2025-02-12

Similar Documents

Publication Publication Date Title
AU2015282127B2 (en) Method for producing fused heterocyclic compound
EP4506334A1 (en) Trifluoromethane sulfonylation agent composition and method for producing trifluoromethanesulfonyloxy compound or trifluoromethane sulfonyl compound
US10513506B2 (en) 4-((6-(2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propyl)pyridin-3-yl and processes of preparation
TWI765942B (zh) 三環化合物之製備方法
WO2007094313A1 (ja) 2-(置換フェニル)-3,3,3-トリフルオロプロペン化合物の製造方法
US20060155129A1 (en) Processes for preparing aromatic ethers
US8664402B2 (en) Process for preparing 1-(6-methylpyridin-3-yl)-2-[4-(methylsulfonyl)phenyl]ethanone, an intermediate of etoricoxib
KR100895191B1 (ko) 1,3-프로펜설톤의 제조방법
JP5679855B2 (ja) ジフルオロメチル化ヘテロアリール化合物の製造方法
WO2011090122A1 (ja) 2-アミノ-4-トリフルオロメチルピリジン類の製造方法
JP7353295B2 (ja) 2,6-ジアルキルフェニル酢酸の製造方法
JP5516567B2 (ja) 4−アミノ−2−アルキルチオ−5−ピリミジンカルバルデヒドの製法
KR101837072B1 (ko) N-(2,2-디플루오로에틸)프로프-2-엔-1-아민으로부터 2,2-디플루오로에틸아민 유도체의 제조방법
US8030512B2 (en) Polycyclic pentafluorosulfanylbenzene compound and process for producing the compound
WO2025094700A1 (ja) トリフルオロメタンスルホニル化剤組成物、及び、トリフルオロメタンスルホニルオキシ化合物の製造方法
JP7385604B2 (ja) ピリドン化合物の製造方法
JP5205971B2 (ja) テトラヒドロピラン化合物の製造方法
JP2026017828A (ja) モノフルオロスルホニル化剤組成物、モノフルオロスルホニルオキシ化合物の製造方法、及び、新規化合物
AU2024364337A1 (en) Processes for the preparation of substituted phenylacetonitriles and substituted phenylacetic acids
WO2018163818A1 (ja) トリアゾール化合物の製造方法
JP2001247508A (ja) オレフィン化合物の製造方法
WO2025150497A1 (ja) トリフルオロメタンスルホンアミド化合物の製造方法
HK40113433A (en) Process for producing isoxazoline-5,5-vinylcarboxylic acid derivatives
CN108473431B (zh) 2-氨基烟酸苄酯衍生物的制造方法
US20060069284A1 (en) Esters of allyl substituted by a difluoromethylene group, method for the synthesis thereof and use thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 23799482

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 202380037379.0

Country of ref document: CN

Ref document number: 2023799482

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2024519216

Country of ref document: JP

ENP Entry into the national phase

Ref document number: 2023799482

Country of ref document: EP

Effective date: 20241030

NENP Non-entry into the national phase

Ref country code: DE

WWP Wipo information: published in national office

Ref document number: 18862440

Country of ref document: US